Vaso (VASO) Short-Term Capital Lease Obligation : $0.96 Mil (As of Mar. 2024)

View and export this data going back to 2006. Start your Free Trial

What is Vaso Short-Term Capital Lease Obligation?

Vaso's Short-Term Capital Lease Obligation for the quarter that ended in Mar. 2024 was $0.96 Mil.

Vaso's quarterly Short-Term Capital Lease Obligation increased from Sep. 2023 ($0.90 Mil) to Dec. 2023 ($1.00 Mil) but then declined from Dec. 2023 ($1.00 Mil) to Mar. 2024 ($0.96 Mil).

Vaso's annual Short-Term Capital Lease Obligation increased from Dec. 2021 ($0.78 Mil) to Dec. 2022 ($0.87 Mil) and increased from Dec. 2022 ($0.87 Mil) to Dec. 2023 ($1.00 Mil).

Vaso Short-Term Capital Lease Obligation Historical Data

The historical data trend for Vaso's Short-Term Capital Lease Obligation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Vaso Short-Term Capital Lease Obligation Chart

Vaso Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Short-Term Capital Lease Obligation

Get a 7-Day Free Trial

0.72

0.73

0.78

0.87

1.00

Vaso Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Short-Term Capital Lease Obligation	Get a 7-Day Free Trial															0.87	0.89	0.90	1.00	0.96

Vaso Short-Term Capital Lease Obligation Explanation

Short-Term Capital Lease Obligation represents the total amount of Long-Term Capital Lease Obligation that must be paid within the next accounting period. Capital lease obligations are contractual obligations that arise from obtaining the use of property or equipment via a capital lease contract.

Vaso Short-Term Capital Lease Obligation Related Terms

Thank you for viewing the detailed overview of Vaso's Short-Term Capital Lease Obligation provided by GuruFocus.com. Please click on the following links to see related term pages.

Vaso (VASO) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Vaso Corporation (OTCPK:VASO) » Definitions » Short-Term Capital Lease Obligation

Comparable Companies

Traded in Other Exchanges

N/A

Address

137 Commercial Street, Unit 200, Plainview, NY, USA, 11803

Website

https://www.vasocorporation.com

Vaso Corporation is a medical technology company. It provides diverse product and service categories, including noninvasive monitoring and therapeutic devices, diagnostic imaging equipment, and information technology for enterprises and clinical customers. The company currently operates in three distinct business units namely IT; Professional sales and Equipment. It generates maximum revenue from the IT segment. IT segment focuses on healthcare IT and managed network technology services.

Executives

Leon Dembo	director	137 COMMERCIAL STREET, SUITE 200, PLAINVIEW NY 11803
Janey Moen	director	137 COMMERCIAL STREET, SUITE 200, PLAINVIEW NY 11803
Jun Ma	director	C/O VASOMEDICAL, INC., 180 LINDEN AVENUE, WESTBURY NY 11590
Edgar Rios	director	1650 TYSONS BOULEVARD, SUITE 900, MCLEAN VA 22102
Michael Beecher	officer: Chief Financial Officer	C/O DIRECT INSITE CORP, 80 ORVILLE DRIVE, BOHEMIA NY 11716
Joshua Markowitz	director	3131 PRINCETON PIKE, BLDG. 3D, SUITE 200, LAWRENCEVILLE NJ 08648
Jonathan P Newton	officer: Vice Pres Finance & Controller	152 RICHMOND AVENUE, AMITYVILLE NY 11701
Peter C Castle	director	C/O NETWOLVES CORP, 4002 EISENHOWER BLVD, TEMPA FL 33634
David H Lieberman	director	3061 INDUSTRY DR, LANCASTER PA 17603
Behnam Movaseghi	director	C/O KERNS MANUFACTURING CORPORATION, 37-14 29TH STREET, LONG ISLAND CITY NY 11101
Nelson Randall Hill	officer: Senior Vice President	3880 EAST COUNTY HIGHWAY 30A, UNIT 201, SANTA ROSA BEACH FL 24159
William Edward Dempsey	director	52 PARK AVENUE, SANDYMOUNT L2 DUBLIN 4
David Tarachand Singh	officer: Chief Financial Officer	C/O VASOMEDICAL, INC., 180 LINDEN AVENUE, WESTBURY NY 11590
Joseph Giacalone	director
Derek Enlander	director	88C UNION AVENUE, CENTER MORICHES NY 11934